Logical Biological recognized as one of ‘Europe’s fastest-growing companies’ due to customer centric approach and quality commitment

Logical Biological specialise in providing human serum, plasma, swabs, tissues, PBMCs and other biological specimens for diagnostics and therapeutic research and development.

Surmodics agrees to $627M private equity buyout

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Surmodics, a maker of medical

May 31, 2024

Sickle Cell Disease patients and the use of disease-modifying treatments

New disease-modifying treatments (DMTs), namely, crizanlizumab, L-glutamine, and voxelotor, have recently been approved.

November 23, 2023

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September – Biotech Investments

Issuer: Immunic AG / Key word(s): Conference 28.08.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Host

August 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.